QLYS Insider Activity: Thakar Exercises 6,500 Options and Sells 8,500 Shares
Rhea-AI Filing Summary
Qualys insider transactions by CEO Sumedh S. Thakar: The filing shows the CEO exercised 6,500 stock options with a $25.56 exercise price and immediately acquired 6,500 shares. On the same date, under a Rule 10b5-1 trading plan adopted February 26, 2025, he sold 5,722 shares at a weighted average price of $129.6697 and sold 2,778 shares at a weighted average price of $130.5372, for total shares sold of 8,500. Beneficial ownership reported moved from 216,420 shares following the option acquisition to 207,920 after the sales. The option granted is fully vested and exercisable and the sales were executed pursuant to the disclosed 10b5-1 plan.
Positive
- Transactions executed under a Rule 10b5-1 plan, which provides pre-arranged, compliant framework for insider sales
- Option was fully vested and immediately exercisable, enabling a timely, authorized exercise
- Clear disclosure of weighted average sale prices and offer to provide per-price breakdown on request
Negative
- Insider sold 8,500 shares, reducing beneficial ownership from 216,420 to 207,920
- Form shows insider liquidity, which may be perceived negatively by some investors despite being pre-planned
Insights
TL;DR: Insider exercised vested options and executed planned sales under a 10b5-1 plan, reflecting routine, pre-arranged liquidity.
The filing documents a standard executive liquidity event: exercise of 6,500 options at $25.56 and subsequent sales of 8,500 shares under a Rule 10b5-1 plan adopted Feb 26, 2025. The use of a 10b5-1 plan reduces insider trading risk and signals pre-planned disposition rather than opportunistic sales. Beneficial ownership decreased modestly from 216,420 to 207,920 shares, which is not a material shift in control. Documentation appears complete, including executor signature by POA.
TL;DR: Transactions are operationally routine; sales occurred at ~5x the exercise price, crystallizing gains.
The CEO exercised options with a $25.56 strike and sold shares at weighted average prices of approximately $129.67 and $130.54, realizing a substantial per-share spread over the exercise price. The sales were executed under a 10b5-1 plan, indicating pre-specified timing. Net outstanding common shares reported for the insider after transactions are 207,920, with 26,000 shares represented by vested options still held as derivative positions. From a market perspective, these are non-transactional signals rather than indicators of company operational change.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) | 6,500 | $0.00 | -- |
| Exercise | Common Stock | 6,500 | $25.56 | $166K |
| Sale | Common Stock | 5,722 | $129.6697 | $742K |
| Sale | Common Stock | 2,778 | $130.5372 | $363K |
Footnotes (1)
- The sale transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 26, 2025. The sale price represents the weighted average price of the shares sold ranging from $129.20 to $130.19 per share. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. The sale price represents the weighted average price of the shares sold ranging from $130.20 to $131.10 per share. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. The option is fully vested and immediately exercisable.
FAQ
What did Qualys CEO Sumedh Thakar do according to the Form 4?
Were the sales part of a 10b5-1 trading plan?
What were the weighted average sale prices reported?
Is the exercised option vested and exercisable?